Consistently, loss of STARD7 increases ferroptosis sensitivity in therapy-resistant colorectal cancer models by reducing the delivery of CoQ to the plasma membrane
Among the obesity & weight loss management segment, Novo Nordisks Wegovy (semaglutide) sub-segment held the largest revenue, whereas Eli Lillys Zepbound (tirzepatide) sub-segment expected to register the fastest double-digit growth rate during the forecast period
Rakesh Bobba, Consultant Endocrinology & Diabetology at Aster Ramesh Hospitals, shares expert insights on Tirzepatide and Semaglutide injections, two newly approved medications in India that are achieving promising outcomes in obesity management
Association of mixed exposure to microplastics with sperm dysfunction: a multi-site study in China
GLP-1 weight-management medications are generally not used during pregnancy
L., Arango, C., & Parellada, M